P. D’Agostino
About
In The Last Decade
P. D’Agostino
27 papers receiving 538 citations
Peers
Comparison fields: 5 of 92
- Immunology 148
- Public Health, Environmental and Occupational Health 116
- Epidemiology 95
- Endocrinology, Diabetes and Metabolism 74
- Rheumatology 70
Countries citing papers authored by P. D’Agostino
This map shows the geographic impact of P. D’Agostino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. D’Agostino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. D’Agostino more than expected).
Fields of papers citing papers by P. D’Agostino
This network shows the impact of papers produced by P. D’Agostino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. D’Agostino. The network helps show where P. D’Agostino may publish in the future.
Co-authorship network of co-authors of P. D’Agostino
This figure shows the co-authorship network connecting the top 25 collaborators of P. D’Agostino. A scholar is included among the top collaborators of P. D’Agostino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. D’Agostino. P. D’Agostino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | Production of cytokines at the operation site. | 7 |
| 3 | 23 | |
| 4 | 28 | |
| 5 | 24 | |
| 6 | 203 | |
| 7 | 13 | |
| 8 | 10 | |
| 9 | 8 | |
| 10 | 18 | |
| 11 | 37 | |
| 12 | 20 | |
| 13 | 3 | |
| 14 | 6 | |
| 15 | 2 | |
| 16 | 3 | |
| 17 | 5 | |
| 18 | Detection of two associated precipitating autoantibodies (DA1 and DA2) in sera from patients with systemic lupus erythematosus. | 2 |
| 19 | Antibodies to Epstein-Barr virus and cytomegalovirus in primary Sjogren's syndrome. | 6 |
| 20 | Anti-Epstein-Barr virus antibodies in systemic lupus erythematosus. | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.